Gabapentin: A new tool in the treatment of neuropathic pain

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Human neuropathic pain remains a prevalent and pervasive problem in our society. Pharmacologically there is also no single, uniformly well-tolerated drug that is reliably helpful. Gabapentin has emerged as a useful new tool based on the results of two large multicenter trials in models of human neuropathy. Gabapentin proved to be a significantly better analgesic than placebo, was well tolerated in the elderly population, and had a significant positive impact on several subjective and objective outcome measures. A discussion of the standard treatments and the studies supporting this new tool is the purpose of this review.

Original languageEnglish (US)
Pages (from-to)43-47
Number of pages5
JournalActa Neurologica Scandinavica, Supplement
Issue number173
StatePublished - 1999


  • Diabetic peripheral neuropathy
  • Gabapentin
  • Neuropathic pain
  • Postherpetic neuralgia

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Gabapentin: A new tool in the treatment of neuropathic pain'. Together they form a unique fingerprint.

Cite this